drugset / Trial / NCT00251927

Esomeprazole (NEXIUM) vs. Surgery

NCT00251927 ↗

Phase 3 Completed 626 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The study investigates the efficacy of long-term treatment of esomeprazole compared to anti-reflux surgery in the control of gastroesophageal reflux disease by assessing time to treatment failure.

Timeline

Start
2001-10
Primary completion
2009-04
Completion
2009-04

Outcome

Met primary endpoint

paper Estimated remission rates at 5 years were 92% (95% confidence interval [CI], 89%-96%) in the esomeprazole group and 85% (95% CI, 81%-90%) in the LARS group (log-rank P = .048). PMID 21586712 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg Oral